Tritanrix-HepB/Meningitec conjugate vaccine

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

DiphtheriaHaemophilus Influenzae Type bHepatitis BTetanusWhole Cell Pertussis

Phase 3

Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

CompletedNCT00317135

GlaxoSmithKlineDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +2

Start: 2003-12-11End: 2004-10-23Updated: 2018-08-15

Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

CompletedNCT00317187

GlaxoSmithKlineDiphtheria, Haemophilus Influenzae Type b, Hepatitis B +2

Start: 2004-06-08End: 2005-01-16Updated: 2018-08-15